Zytux Rituximab Injection 500mg 50ml In Pakistan

Zytux Rituximab 500mg/50ml In Pakistan | Price & Details

Zytux Rituximab Injection 500mg/50ml is a prescription biological medicine containing rituximab, a monoclonal antibody that targets the CD20 protein found on B lymphocytes. It is used under specialist medical supervision for certain blood cancers and selected autoimmune or immune-mediated conditions.

Each 50 mL vial contains 500 mg of rituximab, equivalent to a concentration of 10 mg/mL. Zytux is supplied as a concentrate for preparation of an intravenous infusion.

Benefits

• Contains rituximab, an anti-CD20 monoclonal antibody.
• Used in specialist treatment protocols for selected B-cell blood cancers.
• May be used for certain autoimmune and immune-mediated diseases when rituximab therapy is appropriate.
• Available in a 500 mg/50 mL vial for intravenous infusion.
• Provides a standardized rituximab formulation for specialist hospital use.

Specification

• Brand: Zytux
• Generic Name: Rituximab
• Strength: 500 mg/50 mL
• Concentration: 10 mg/mL
• Dosage Form: Concentrate for solution for infusion
• Route: Intravenous (IV) infusion
• Pack Size: 1 vial x 50 mL
• Active Ingredient: Rituximab
• Product Type: Prescription biological medicine
• Manufacturer listed by DRAP: CCL Pharmaceuticals (Pvt.) Ltd.

How to Use

Zytux must be administered only by a qualified healthcare professional through intravenous infusion. It should not be self-administered or given as an intravenous push or bolus. The prescribed dose and treatment schedule depend on the specific medical condition, treatment protocol, body surface area or other clinical factors.

Before administration, the required amount is prepared and diluted in an appropriate sterile infusion solution according to the official product instructions. Patients are monitored during treatment because rituximab can cause infusion-related reactions.

The treating physician may perform appropriate screening and monitoring before and during therapy, including assessment of infection risks. Do not use Zytux without a specialist’s prescription and supervision.

Why Choose Zytux?

• Contains the established active ingredient rituximab.
• 500 mg/50 mL presentation suitable for specialist IV infusion protocols.
• Listed by Pakistan’s DRAP pharmaceutical pricing database as a 500 mg/50 mL rituximab product.
• Used in specialist oncology and immunology settings for approved indications.
• Available as a prescription biological medicine in Pakistan.